User menu

Sleep apnoea syndrome and 10-year cardiovascular risk in females with type 2 diabetes: relationship with insulin secretion and insulin resistance

Bibliographic reference Hermans, Michel ; Ahn, Sylvie A ; Mahadeb, Parikshat Yovan ; Rousseau, Michel. Sleep apnoea syndrome and 10-year cardiovascular risk in females with type 2 diabetes: relationship with insulin secretion and insulin resistance. In: Diabetes - Metabolism: Research and Reviews (Print), Vol. 29, no.3, p. 227-234 (2013)
Permanent URL http://hdl.handle.net/2078.1/132418
  1. Harsch, Med Sci Monit, 11, 70 (2005)
  2. West S D, Nicoll D J, Stradling J R, Prevalence of obstructive sleep apnoea in men with type 2 diabetes, 10.1136/thx.2005.057745
  3. Hermans Michel P., Ahn Sylvie A., Rousseau Michel F., Cardiometabolic phenotype and UKPDS risk in male type 2 diabetic patients with obstructive sleep apnoea, 10.1016/j.dsx.2008.10.011
  4. Pillai Anita, Warren Graham, Gunathilake Waruna, Idris Iskandar, Effects of Sleep Apnea Severity on Glycemic Control in Patients with Type 2 Diabetes Prior to Continuous Positive Airway Pressure Treatment, 10.1089/dia.2011.0005
  5. Hermans, J Clin Metab Diab, 2, 64 (2011)
  6. Hermans Michel P., Ahn Sylvie A., Rousseau Michel F., Neurohormonal biomarkers and UKPDS stroke risk in type 2 diabetic women on primary cardiovascular prevention, 10.1016/j.dsx.2008.02.001
  7. MORTIMORE I. L., MARSHALL I., WRAITH P. K., SELLAR R. J., DOUGLAS N. J., Neck and Total Body Fat Deposition in Nonobese and Obese Patients with Sleep Apnea Compared with That in Control Subjects, 10.1164/ajrccm.157.1.9703018
  8. Sleep–Related Breathing Disorders in Adults: Recommendations for Syndrome Definition and Measurement Techniques in Clinical Research, 10.1093/sleep/22.5.667
  9. Sadikot S.M., An overview: Obstructive Sleep Apnea and the Metabolic Syndrome: Should “X” be changed to “Zzz…Zzzz….Zzzzzzzzz….Zzz”?, 10.1016/j.dsx.2007.09.011
  10. Pillar G., Shehadeh N., Abdominal Fat and Sleep Apnea: The chicken or the egg?, 10.2337/dc08-s272
  11. Dancey David R., Hanly Patrick J., Soong Christine, Lee Bert, Shepard John, Hoffstein Victor, Gender Differences in Sleep Apnea, 10.1378/chest.123.5.1544
  12. Kapsimalis Fotis, Kryger Meir, Sleep Breathing Disorders in the U.S. Female Population, 10.1089/jwh.2008.1054
  13. Yukawa Kumiko, Inoue Yuichi, Yagyu Hisanaga, Hasegawa Tatsuya, Komada Yoko, Namba Kazuyoshi, Nagai Noriko, Nemoto Shoko, Sano Erika, Shibusawa Minoru, Nagano Naoko, Suzuki Mamoru, Gender Differences in the Clinical Characteristics Among Japanese Patients With Obstructive Sleep Apnea Syndrome, 10.1378/chest.08-1414
  14. Celen, J Clin Sleep Med, 6, 244 (2010)
  15. Campos-Rodriguez Francisco, Martinez-Garcia Miguel A., de la Cruz-Moron Ines, Almeida-Gonzalez Carmen, Catalan-Serra Pablo, Montserrat Josep M., Cardiovascular Mortality in Women With Obstructive Sleep Apnea With or Without Continuous Positive Airway Pressure Treatment : A Cohort Study, 10.7326/0003-4819-156-2-201201170-00006
  16. Singh, J Gend Specif Med, 4, 28 (2001)
  17. Mosca Lori, Appel Lawrence J, Benjamin Emelia J, Berra Kathy, Chandra-Strobos Nisha, Fabunmi Rosalind P, Grady Deborah, Haan Constance K, Hayes Sharonne N, Judelson Debra R, Keenan Nora L, McBride Patrick, Oparil Suzanne, Ouyang Pamela, Oz Mehmet C, Mendelsohn Michael E, Pasternak Richard C, Pinn Vivian W, Robertson Rose Marie, Schenck-Gustafsson Karin, Sila Cathy A, Smith Sidney C, Sopko George, Taylor Anne L, Walsh Brian W, Wenger Nanette K, Williams Christine L, Evidence-based guidelines for cardiovascular disease prevention in women 11The American Heart Association makes every effort to avoid any actual or potential conflicts of interest that may arise as a result of an outside relationship or a personal, professional, or business interest of a member of the writing panel. Specifically, all members of the writing group are required to complete and submit a Disclosure Questionnaire showing all such relationships that might be perceived as real or potential conflicts of interest.This statement was approved by the American Heart Association Science Advisory and Coordinating Committee and by the American College of Cardiology Foundation in December 2003. This document is available on the World Wide Web sites of the American College of Cardiology (http://www.acc.org) and the American Heart Association (http://www.americanheart.org). A single reprint is available by calling 800-242-8721 (US only) or writing the American Heart Association, Public Information, 7272 Greenville Ave, Dallas, TX 75231-4596. Ask for reprint No. 71–0276. To purchase additional reprints: up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies, call 410-528-4121, fax 410-528-4264, or e-mail kgray@lww.com. To make photocopies for personal or educational use, call the Copyright Clearance Center, 978-750-8400.(J Am Coll Cardiol 2004;43:900–21)The online-only Data Supplement is available athttp://www.acc.org., 10.1016/j.jacc.2004.02.001
  18. Legato Marianne J., Gelzer Andrea, Goland Robin, Ebner Susana A., Rajan Sabitha, Villagra Victor, Kosowski Mark, Gender-specific care of the patient with diabetes: Review and recommendations, 10.1016/s1550-8579(06)80202-0
  19. Johns Murray W., A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale, 10.1093/sleep/14.6.540
  20. Johns Murray W., Daytime Sleepiness, Snoring, and Obstructive Sleep Apnea, 10.1378/chest.103.1.30
  21. International Diabetes Federation The IDF Consensus Statement on sleep apnoea and Type 2 diabetes 2008 1 23 www.idf.org/sleep-apnoea-and-type-2-diabetes
  22. Stevens R. J., Coleman R. L., Adler A. I., Stratton I. M., Matthews D. R., Holman R. R., Risk Factors for Myocardial Infarction Case Fatality and Stroke Case Fatality in Type 2 Diabetes: UKPDS 66, 10.2337/diacare.27.1.201
  23. , Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, 10.2337/diacare.20.7.1183
  24. Valdez, Int J Obes, 16, 77 (1992)
  25. Kyle Ursula G, Morabia Alfredo, Schutz Yves, Pichard Claude, Sedentarism affects body fat mass index and fat-free mass index in adults aged 18 to 98 years, 10.1016/j.nut.2003.11.019
  26. Burkhauser Richard V., Cawley John, Beyond BMI: The value of more accurate measures of fatness and obesity in social science research, 10.1016/j.jhealeco.2007.05.005
  27. Davies, Eur Respir J, 3, 509 (1990)
  28. Alberti K.G.M.M., Eckel R. H., Grundy S. M., Zimmet P. Z., Cleeman J. I., Donato K. A., Fruchart J.-C., James W. P. T., Loria C. M., Smith S. C., Harmonizing the Metabolic Syndrome: A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity, 10.1161/circulationaha.109.192644
  29. Levy J. C., Matthews D. R., Hermans M. P., Correct Homeostasis Model Assessment (HOMA) Evaluation Uses the Computer Program, 10.2337/diacare.21.12.2191
  30. Hermans M. P., Levy J. C., Morris R. J., Turner R. C., Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetes, 10.1007/s001250051215
  31. Munoko Thierry N., Hermans Michel P., Phenotypic characterization of first generation Maghrebian migrants with type 2 diabetes, 10.1016/j.dsx.2008.02.004
  32. Cockcroft Donald W., Gault Henry, Prediction of Creatinine Clearance from Serum Creatinine, 10.1159/000180580
  33. Levey Andrew S., A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation, 10.7326/0003-4819-130-6-199903160-00002
  34. Kiely J.L., McNicholas W.T., Cardiovascular risk factors in patients with obstructive sleep apnoea syndrome, 10.1034/j.1399-3003.2000.16a23.x
  35. Meslier N., Gagnadoux F., Giraud P., Person C., Ouksel H., Urban T., Racineux J-L., Impaired glucose-insulin metabolism in males with obstructive sleep apnoea syndrome, 10.1183/09031936.03.00089902
  36. Hatipoğlu Umur, Rubinstein Israel, Inflammation and Obstructive Sleep Apnea Syndrome Pathogenesis: A Working Hypothesis, 10.1159/000075218
  37. Oltmanns Kerstin M., Gehring Hartmut, Rudolf Sebastian, Schultes Bernd, Rook Stefanie, Schweiger Ulrich, Born Jan, Fehm Horst L., Peters Achim, Hypoxia Causes Glucose Intolerance in Humans, 10.1164/rccm.200308-1200oc
  38. Dincer H. Erhan, O’Neill William, Deleterious Effects of Sleep-Disordered Breathing on the Heart and Vascular System, 10.1159/000089814
  39. Peker Y., Carlson J., Hedner J., Increased incidence of coronary artery disease in sleep apnoea: a long-term follow-up, 10.1183/09031936.06.00107805
  40. Zouaoui Boudjeltia Karim, van Meerhaeghe Alain, Doumit Sonia, Guillaume Michel, Cauchie Philippe, Brohée Dany, Vanhaeverbeek Michel, Kerkhofs Myriam, Sleep Apnoea-Hypopnoea Index Is an Independent Predictor of High-Sensitivity C-Reactive Protein Elevation, 10.1159/000090201
  41. Kaparianos, Eur Rev Med Pharmacol Sci, 10, 319 (2006)
  42. McNicholas W. T., Bonsignore M. R., , Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities, 10.1183/09031936.00027406
  43. Sharma Surendra K., Agrawal Swastik, Damodaran Deepak, Sreenivas Vishnubhatla, Kadhiravan Tamilarasu, Lakshmy Ramakrishnan, Jagia Priya, Kumar Atin, CPAP for the Metabolic Syndrome in Patients with Obstructive Sleep Apnea, 10.1056/nejmoa1103944
  44. Hermans, Recent Advances in the Pathogenesis, Prevention and Management of Type 2 Diabetes and its Complications (2011)
  45. Carey Vincent J., Bishop Louise, Laranjo Nancy, Harshfield Benjamin J., Kwiat Carolyn, Sacks Frank M., Contribution of High Plasma Triglycerides and Low High-Density Lipoprotein Cholesterol to Residual Risk of Coronary Heart Disease After Establishment of Low-Density Lipoprotein Cholesterol Control, 10.1016/j.amjcard.2010.05.002
  46. Hermans Michel P, Ahn Sylvie A, Rousseau Michel F, log(TG)/HDL-C is related to both residual cardiometabolic risk and β-cell function loss in type 2 diabetes males, 10.1186/1475-2840-9-88
  47. Hermans Michel P, Fruchart Jean-Charles, Reducing residual vascular risk in patients with atherogenic dyslipidemia: where do we go from here?, 10.2217/clp.10.65
  48. Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies, 10.1016/s0140-6736(10)60545-4
  49. Hermans Michel P., Fruchart Jean-Charles, Reducing vascular events risk in patients with dyslipidaemia: an update for clinicians, 10.1177/2040622311413952
  50. Cohen P.G., The hypogonadal–obesity cycle: role of aromatase in modulating the testosterone–estradiol shunt – a major factor in the genesis of morbid obesity, 10.1054/mehy.1997.0624
  51. Sanford Stacy D., Lichstein Kenneth L., Durrence H. Heith, Riedel Brant W., Taylor Daniel J., Bush Andrew J., The influence of age, gender, ethnicity, and insomnia on Epworth sleepiness scores: A normative US population, 10.1016/j.sleep.2006.01.010